Free Trial

Galmed Pharmaceuticals (GLMD) News Today

Galmed Pharmaceuticals logo
$1.38 -0.01 (-0.72%)
Closing price 08/28/2025 04:00 PM Eastern
Extended Trading
$1.37 -0.01 (-0.72%)
As of 06:25 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

GLMD Latest News

Galmed awarded extension of Aramchol patent protection to 2039
Galmed Pharmaceuticals Amends Equity Purchase Agreement
Financial markets news icon
MarketBeat Week in Review – 9/16 - 9/20 (GLMD)
Stocks got a boost as the Federal Reserve cut interest rates, but investors should expect more volatility as economic data continues to deliver mixed signals...
Cropped view of biologist in medical mask and latex gloves holding syringe near microscope — Photo
Galmed Pharmaceuticals Surges 400%: What's Behind the Explosion?
Galmed Pharmaceuticals (NASDAQ: GLMD) stock skyrocketed nearly 400%, trading over 80 million shares, compared to its average of 75,000.
Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals (NASDAQ: GLMD)
Galmed Pharmaceuticals Ltd (GPH.BE)
Galmed Pharmaceuticals Ltd. (GPH.F)
Get Galmed Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for GLMD and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

GLMD Media Mentions By Week

GLMD Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

GLMD
News Sentiment

0.98

1.03

Average
Medical
News Sentiment

GLMD News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

GLMD Articles
This Week

5

0

GLMD Articles
Average Week

Get the Latest News and Ratings for GLMD and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Galmed Pharmaceuticals and its competitors.

Sign Up
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


This page (NASDAQ:GLMD) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners